Invention Grant
- Patent Title: Methods for continuous manufacture of liposomal drug products
-
Application No.: US16981149Application Date: 2019-03-29
-
Publication No.: US11571386B2Publication Date: 2023-02-07
- Inventor: Robert Worsham
- Applicant: Insmed Incorporated
- Applicant Address: US NJ Bridgewater
- Assignee: Insmed Incorporated
- Current Assignee: Insmed Incorporated
- Current Assignee Address: US NJ Bridgewater
- Agency: Cooley LLP
- International Application: PCT/US2019/024901 WO 20190329
- International Announcement: WO2019/191627 WO 20191003
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K31/145 ; A61K31/4174 ; A61K31/4196 ; A61K31/42 ; A61K31/4375 ; A61K31/496 ; A61K31/5025 ; A61K31/505 ; A61K31/65 ; A61K31/7036 ; A61K31/7048 ; A61K38/14 ; B01F23/41 ; B01F101/22
Abstract:
Provided herein are methods for making liposomal API formulations via continuous in-line diafiltration processes. Also provided herein are liposomal API formulations manufactured by the disclosed methods.
Public/Granted literature
- US20210015750A1 METHODS FOR CONTINUOUS MANUFACTURE OF LIPOSOMAL DRUG PRODUCTS Public/Granted day:2021-01-21
Information query
